Rhonda discusses the bioavailability of sulforaphane from various supplements, revealing that some formulations can deliver as little as 10% of the active compound to the bloodstream. She highlights the troubling prevalence of misleading ingredient claims in the supplement industry, noting that many products often contain ineffective substitutes instead of the promised ingredients. The conversation sheds light on the need for consumers to be cautious and informed when selecting supplements.
